跳至主要内容
临床试验/CTRI/2026/01/101281
CTRI/2026/01/101281招募中2/3 期

Randomized controlled clinical study to evaluate the efficacy of chavyadimadhu yoga with vidangadi churna in the management of medoroga with special reference to visceral fat and hyperlipidemia

Shweta Bharat Shinde1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2026年2月9日最近更新:

试验速览

阶段
2/3 期
状态
招募中
发起方
入组人数
110
试验地点
1

研究概览

简要总结

This Study is a Randomized Open Labelled Controlled Clinical Trial Comparing the Safety and Efficacy of Chavyadimadhu Yoga 3gm and Sattu 6gm with Madhu BD and Controlled Drug Vidangadi Churna 3gm with Madhu BD For 28 Days in 110 Patients of Medoroga Divided in Two Groups and the Effect on Total Serum Cholesterol , Serum Triglycerides , Serum LDL ,Serum HDL , Serum VLDL , Weight , BMI , Waist Circumferecne ,Hip circumferemce , Mid upper arm circumference , Skin flod thickness , Visceral fat will be assessed before and after treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient with BMI greater than 25 kilogram per meter square and less than 40 kilogram per meter square.
  • 2.Patient present with any 3 classical signs and symptoms of Ashtodosha of Medorog.
  • Patients who give informed consent should involve.

排除标准

  • Patient with BMI greater than 40 kilogram per meter square.
  • Pregnant and lactating mother.
  • Patient having history of Renal disease, HIV, HbsAg.
  • Patient having acute complication like Coronary Heart Disease (CHD), Acute infective hepatitis and Alcoholic hepatitis.
  • Patient having known case of carcinoma of any type in the body
  • Patient having endocrine disorder like hypothyroidism and diabetes.
  • Patient on prolonged medication with corticosteroid, NSAIDs, Antidepressant.

研究者

发起方
Shweta Bharat Shinde
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Shweta Bharat Shinde

Siddhakala Ayurveda college and research center sangamner

研究点 (1)

Loading locations...

相似试验